)
)
Chinook Therapeutics Investor Relations Material
Latest events
Investor Update
Chinook Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Chinook Therapeutics Inc
Access all reports
Chinook Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's pipeline targets rare, severe chronic kidney conditions, aiming to address unmet medical needs in areas such as immunoglobulin A (IgA) nephropathy and other forms of glomerular diseases. Chinook leverages advanced research technologies and a deep understanding of kidney biology to develop innovative therapies designed to slow or prevent disease progression. The company is headquartered in Seattle, Washington, and its shares are listed on the Nasdaq.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
KDNY
Country
🇺🇸 United States